investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

Matthew L. Meyerson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Matthew L. Meyerson

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Roman Perez-Soler

Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy

Trachea, bronchus and lung

Brid Ryan

Examining the Inverse Relationship Between Parkinson's Disease and Lung Cancer

Trachea, bronchus and lung

Pathology

Pinar Ozden Eser

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Trachea, bronchus and lung

Kwok Kin Wong

In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap

Trachea, bronchus and lung

Martin Mcmahon

Studying the Initiation, Progression and Therapy of Lung Cancer in Mouse Models

Trachea, bronchus and lung

Pathology

Eusebio Manchado-Robles

Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers

Trachea, bronchus and lung

Deborah Morrison

Role of Protein Scaffolds in RTK/Ras-Dependent Signal Transduction

Trachea, bronchus and lung

Philip Tofilon

Radiation-induced translational control of gene expression

Trachea, bronchus and lung

Radiation Oncology

Simon D Spivack

Risk for Lung Cancer Asthma and COPD; Integrating Clinical and Airway Biomarker

Trachea, bronchus and lung